HomeCompareTTNP vs PM

TTNP vs PM: Dividend Comparison 2026

TTNP yields 85.47% · PM yields 3.48%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TTNP wins by $2.06M in total portfolio value
10 years
TTNP
TTNP
● Live price
85.47%
Share price
$2.34
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2.11M
Annual income
$639,398.81
Full TTNP calculator →
PM
Philip Morris International
● Live price
3.48%
Share price
$165.34
Annual div
$5.76
5Y div CAGR
17.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$2,492.02
Full PM calculator →

Portfolio growth — TTNP vs PM

📍 TTNP pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTTNPPM
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TTNP + PM cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TTNP pays
PM pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TTNP
Annual income on $10K today (after 15% tax)
$7,264.96/yr
After 10yr DRIP, annual income (after tax)
$543,488.99/yr
PM
Annual income on $10K today (after 15% tax)
$296.12/yr
After 10yr DRIP, annual income (after tax)
$2,118.22/yr
At 15% tax rate, TTNP beats the other by $541,370.77/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TTNP + PM for your $10,000?

TTNP: 50%PM: 50%
100% PM50/50100% TTNP
Portfolio after 10yr
$1.08M
Annual income
$320,945.41/yr
Blended yield
29.71%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PM right now

TTNP
Analyst Ratings
2
Buy
2
Hold
Consensus: Buy
Altman Z
-240.6
Piotroski
1/9
PM
Analyst Ratings
17
Buy
7
Hold
1
Sell
Consensus: Buy
Price Target
$194.30
+17.5% upside vs current
Range: $180.00 — $205.00
Altman Z
4.0
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TTNP buys
0
PM buys
0
No recent congressional trades found for TTNP or PM in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTTNPPM
Forward yield85.47%3.48%
Annual dividend / share$2.00$5.76
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%17.2%
Portfolio after 10y$2.11M$49.6K
Annual income after 10y$639,398.81$2,492.02
Total dividends collected$1.85M$11.7K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusBuyBuy

Year-by-year: TTNP vs PM ($10,000, DRIP)

YearTTNP PortfolioTTNP Income/yrPM PortfolioPM Income/yrGap
1← crossover$19,247$8,547.01$11,648$408.29+$7.6KTTNP
2$35,969$15,374.24$13,589$495.90+$22.4KTTNP
3$65,338$26,851.55$15,877$603.21+$49.5KTTNP
4$115,497$45,585.62$18,580$734.88+$96.9KTTNP
5$198,892$75,309.60$21,781$896.75+$177.1KTTNP
6$334,016$121,202.50$25,578$1,096.12+$308.4KTTNP
7$547,628$190,230.15$30,092$1,342.17+$517.5KTTNP
8$877,445$291,482.95$35,470$1,646.46+$842.0KTTNP
9$1,375,345$436,479.30$41,892$2,023.58+$1.33MTTNP
10$2,111,018$639,398.81$49,578$2,492.02+$2.06MTTNP

TTNP vs PM: Complete Analysis 2026

TTNPStock

Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform. The company offers Probuphine implant for the maintenance treatment of opioid use disorder in clinically stable patients in Canada and the European Union. It is also developing kappa opioid agonist peptide program (TP-2021) for use in combination with ProNeura technology for the treatment of chronic pruritus; nalmefene implant program for the prevention of opioid relapse following detoxification of patients suffering opioid use disorder; and other programs, including HIV preventative therapeutic and a contraceptive from a single ProNeura implant for women and adolescent girls. The company was incorporated in 1992 and is based in South San Francisco, California.

Full TTNP Calculator →

PMConsumer Staples

Philip Morris International Inc. operates as a tobacco company working to delivers a smoke-free future and evolving portfolio for the long-term to include products outside of the tobacco and nicotine sector. The company's product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, vapor, and oral nicotine products that are sold in markets outside the United States. The company offers its smoke-free products under the HEETS, HEETS Creations, HEETS Dimensions, HEETS Marlboro, HEETS FROM MARLBORO, Marlboro Dimensions, Marlboro HeatSticks, Parliament HeatSticks, and TEREA brands, as well as the KT&G-licensed brands, Fiit, and Miix. It also sells its products under the Marlboro, Parliament, Bond Street, Chesterfield, L&M, Lark, and Philip Morris brands. In addition, the company owns various cigarette brands, such as Dji Sam Soe, Sampoerna A, and Sampoerna U in Indonesia; and Fortune and Jackpot in the Philippines. The company sells its smoke-free products in 71 markets. Philip Morris International Inc. was incorporated in 1987 and is headquartered in New York, New York.

Full PM Calculator →
📬

Get this TTNP vs PM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TTNP vs SCHDTTNP vs JEPITTNP vs OTTNP vs KOTTNP vs MAINTTNP vs MOTTNP vs BTITTNP vs PEP

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.